Concetta M Forchetti MD PhD
Dementia & Geriatrics
Clinical Assistant Professor, Ken and Ruth Davee Department of Neurology, Northwestern University Medical School
Join to View Full Profile
800 Biesterfield Rd.Eberle building suite 610Elk Grove Village, IL 60007
Phone+1 847-981-3630
Fax+1 847-981-3633
Dr. Forchetti is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am the Medical Director for Neuroscience Research and Memory Disorder Clinic at AMITA Health Neurosciences Institute. I am a board certified neurologist with a doctorate degree in neuropharmacology. I completed my post-graduate fellowship at the National Institute of Health. My clinical interests are in generative brain disorders, dementia, including Alzheimer's disease and pharmacological treatment of the above.
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Neurology, 1984 - 1988
NIH Clinical CenterPost-Doctoral Fellowship, 1979 - 1982
Univ L'Aquila- Inst MedClass of 1976
Certifications & Licensure
IL State Medical License 1988 - 2026
PA State Medical License 1986 - 1990
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Cavaliere Della Republica Italiana Republica Italiana, 2006
- CMS Meaningful Use Stage 1 Certification athenaClinicals EHR, athenahealth, Inc, 2013
Clinical Trials
- Acute Effect of Lorazepam on Brain Activity Measured by Magnetoencephalograpy (MEG) and Electroencephalography (EEG) Start of enrollment: 2010 Oct 01
- Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo Start of enrollment: 2013 Jul 01
- A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease Start of enrollment: 2016 Jun 01
Publications & Presentations
PubMed
- 1403 citationsTwo Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's DiseaseStephen Salloway, Reisa A. Sperling, Nick C. Fox, Kaj Blennow, William E. Klunk
The New England Journal of Medicine. 2014-01-23 - 38 citationsGastroretentive gabapentin (G-GR) formulation reduces intensity of pain associated with postherpetic neuralgia (PHN).Christine N. Sang, Rekha Sathyanarayana, Michael O. Sweeney
The Clinical Journal of Pain. 2013-04-01 - 185 citationsMemantine Treatment in Patients with Mild to Moderate Alzheimers Disease Already Receiving a Cholinesterase Inhibitor: A Randomized, Double-Blind, Placebo-Controlled T...Anton P. Porsteinsson, George T. Grossberg, Jacobo Mintzer, Jason T. Olin
Current Alzheimer Research. 2008-01-31
Press Mentions
Brown: Alzheimer’s Deaths Rising — and Why I Take It PersonallyMarch 7th, 2017
Professional Memberships
- Fellow
- Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment (ISTAART)Member
Other Languages
- Italian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
